ySignificant (greater than $10,000) relationship. zDCRI has numerous grants and contracts sponsored by industry. These include the following: Aastrom Biosciencesy; Abbotty; Abiomedy; Acom Cardiovasculary; Adolor Corp.y; Advanced Cardiovascular Systemsy; Advanced Stent Technologiesy; Adynnx; Aijnomotoy; Allergany; Amgeny; Alnylam Pharmay; Alpharmay; Amylin Pharmaceuticalsy; Anadysy; Anesivay; Angel Medical Systemsy; ANGES MGy; Angiomedtrixy; APT Nidus Centery; ASCA Biopharmay; Astellas Pharmay; Asklepiosy; AstraZenecay; Atritechy; Attention Therapeuticsy; Aventisy; Baxtery; Bayery; Berlexy; BG Mediciney; Biogeny; Biolex Therapeuticsy; Biomarker Factoryy; Biositey; Boehringer Ingelheim Biogeny; Boston Scientificy; Bristol-Myers Squibby; BMS Pfizery; Carbomedy; CardioDxy; CardioKinetixy; Cardiovascular Systemsy; Cardiovaxy; Celsion Corp.y; Centocory; Cerexay; Chase Medicaly; Conatus Pharmaceuticalsy; Conor Medsystemsy; Cortexy; Corgentechy; CSL Behringy; CV Therapeuticsy; Daiichi Pharmaceuticalsy; Daiichi Sankyoy; Daiichi Sankyo Lillyy; Datascope; Dendreony; Dainippony; Dr. Reddy s Laboratories; Eclipse Surgical Technologiesy; Edwards Lifesciencesy; Eisaiy; Endicory; EnteroMedicsy; Enzon Pharmaceuticalsy; Eli Lillyy; Ethicony; Ev3y; Evalvey; F2Gy; Flow Cardiay; Fox Hollow Pharmaceuticalsy; Fujisaway; Genetechy; General Electricy; General Electric Co.y; General Electric Healthcarey; General Electric Medical Systemsy; Genzyme Corp.y; Genome Canaday; Gilead Sciencesy; GlaxoSmithKliney; Guidant Corp.y; Heartscape Technologiesy; Hoffman-LaRochey; Hospiray; Idera Pharmaceuticalsy; Ikariay; Imcor Pharmaceuticalsy; Immunexy; INFORMDy; Inimexy; Inspire Pharmaceuticalsy; Ischemixy; Jansseny; Johnson and Johnsony; Jomedy; Juventus Therapeuticsy; KAI Pharmaceuticalsy; King Pharmaceuticalsy; Kyowa Pharmay; Luitpoldy; Mardily; MedImmuney; Medscapey; Medtronic Diabetesy; Medtronicy; Medtronic Vasculary; Merck Groupy; MicroMed Technologyy; Millennium Pharmaceuticalsy; Mitsubishi Tanabey; Momentay; Nabrivay; Neuron Pharmaceuticalsy; NitroMed; NovaCardia Incy; Novartis AG Groupy; Novartis Pharmaceuticalsy; Oncuray; Orexigeny; Ortho-McNeil-Jansseny; OSI Eyetechy; OSI Pharmaceuticalsy; Pfizery; Pharmacyclicsy; Pharmassety; Pharmosy; Phyxius Pharmaceuticals; Pharsighty; Pluristen Therapeuticsy; Portola Pharmaceuticalsy; Proventysy; Radianty; Regado Biosciencesy; Rengeneron Pharmaceuticalsy; Roche Molecular Systemsy; Roche Groupy; Roche Diagnosticy; Salix Pharmaceuticalsy; Sanofi-Pasteur, Inc; Sanofi-aventisy; Santaris Pharmaceuticalsy; Schering-Ploughy; Sciosy; Siemensy; Southwest Oncology Groupy; Spectraneticsy; Summity; Sunovion Pharmaceuticalsy; TAP Pharmaceutical Productsy; Tengiony; The Medicines Companyy; Theravancey; TherOxy; Tethys Biosciencey; Theregeny; Three Rivers Pharmaceuticalsy; The EMMES Corporationy; UCBy; Valentisy; Valleylaby; Vertexy; Viacory; and Wyethy. 